Atrandi Biosciences Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 78

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $25M

  • Investors
  • 7

Atrandi Biosciences General Information

Description

Developer of life sciences research tools designed to enable high-throughput single-cell analysis using compartmentalization technology, operating in the biotechnology research tools industry. The company offers a patented semi-permeable capsule platform that isolates individual cells in discrete, permeable compartments while allowing bulk biochemical reactions, supporting microbial and eukaryotic genomics and single-cell multiomics workflows, enabling researchers to conduct scalable single-cell experiments while preserving single-cell resolution.

Contact Information

Website
www.atrandi.com
Formerly Known As
Droplet Genomics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Savanoriu pr. 178C
  • Vilnius, Vilnius County
  • Lithuania
+370 (0-619)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Savanoriu pr. 178C
  • Vilnius, Vilnius County
  • Lithuania
+370 (0-619)

Atrandi Biosciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Atrandi Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A) 18-Feb-2025 $25M Completed Generating Revenue
2. Seed Round 02-Aug-2023 Completed Generating Revenue
1. Seed Round 09-Nov-2020 $1.18M $1.18M Completed Generating Revenue
To view Atrandi Biosciences’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Atrandi Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of life sciences research tools designed to enable high-throughput single-cell analysis using compartmentaliza
Discovery Tools (Healthcare)
Vilnius, Lithuania
78 As of 2026

Seattle, WA
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Atrandi Biosciences Competitors (6)

One of Atrandi Biosciences’s 6 competitors is Parse Biosciences, a Formerly VC-backed company based in Seattle, WA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Parse Biosciences Formerly VC-backed Seattle, WA
Mission Bio Venture Capital-Backed San Francisco, CA
Partillion Bioscience Venture Capital-Backed Los Angeles, CA
Lightcast (Biotechnology) Venture Capital-Backed Cambridge, United Kingdom
BioSkryb Genomics Venture Capital-Backed Durham, NC
To view Atrandi Biosciences’s complete competitors history, request access »

Atrandi Biosciences Patents

Atrandi Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026202244-A1 Desmulsification of water-in-silicon-oil emulsion Pending 27-Mar-2025
WO-2026109529-A1 Microcapsule crosslinking Pending 22-Nov-2024
AU-2025275094-A1 Microscopy-based microfluidic particle capture Pending 21-May-2024
EP-4684198-A1 Microscopy-based microfluidic particle capture Pending 21-May-2024
US-20250369867-A1 Microscopy-based microfluidic particle capture Pending 21-May-2024 G01N15/149
To view Atrandi Biosciences’s complete patent history, request access »

Atrandi Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Atrandi Biosciences Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
GRIDS Capital Venture Capital Minority
Lux Capital Venture Capital Minority
Metaplanet Holdings Venture Capital Minority
Nordic Mentor Network For Entrepreneurship Accelerator/Incubator Minority
VSquared Ventures Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Atrandi Biosciences FAQs

  • When was Atrandi Biosciences founded?

    Atrandi Biosciences was founded in 2016.

  • Where is Atrandi Biosciences headquartered?

    Atrandi Biosciences is headquartered in Vilnius, Lithuania.

  • What is the size of Atrandi Biosciences?

    Atrandi Biosciences has 78 total employees.

  • What industry is Atrandi Biosciences in?

    Atrandi Biosciences’s primary industry is Discovery Tools (Healthcare).

  • Is Atrandi Biosciences a private or public company?

    Atrandi Biosciences is a Private company.

  • What is Atrandi Biosciences’s current revenue?

    The current revenue for Atrandi Biosciences is .

  • How much funding has Atrandi Biosciences raised over time?

    Atrandi Biosciences has raised $32M.

  • Who are Atrandi Biosciences’s investors?

    GRIDS Capital, Lux Capital, Metaplanet Holdings, Nordic Mentor Network For Entrepreneurship, and VSquared Ventures are 5 of 7 investors who have invested in Atrandi Biosciences.

  • Who are Atrandi Biosciences’s competitors?

    Parse Biosciences, Mission Bio, Partillion Bioscience, Lightcast (Biotechnology), and BioSkryb Genomics are some of the 6 competitors of Atrandi Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process